tumor markers

出典: meddic

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/03/11 00:14:53」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.
  • Long LM1, Zhan JK, Wang HQ, Li S, Chen YY, Liu YS.
  • Pathobiology : journal of immunopathology, molecular and cellular biology.Pathobiology.2017;84(1):38-48. doi: 10.1159/000447302. Epub 2016 Jul 27.
  • BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) exhibits poor prognosis and resistance to chemotherapy. This study was to identify the biomarkers associated with the progression, poor prognosis and chemoresistance of PDAC.METHODS: miR-34a and miR-150 levels in the plasma and tissues from PDAC pa
  • PMID 27458977
  • Dual-responsive immunosensor that combines colorimetric recognition and electrochemical response for ultrasensitive detection of cancer biomarkers.
  • Hong W1, Lee S1, Cho Y2.
  • Biosensors & bioelectronics.Biosens Bioelectron.2016 Dec 15;86:920-6. doi: 10.1016/j.bios.2016.07.014. Epub 2016 Jul 9.
  • We developed a nanoroughened, biotin-doped polypyrrole immunosensor for the detection of tumor markers through dual-signal (electrochemical and colorimetric) channels, electrochemical and colorimetric, that demonstrates remarkable analytical performance. A rapid, one-step electric field-mediated met
  • PMID 27497199
  • Aptamer-initiated on-particle template-independent enzymatic polymerization (aptamer-OTEP) for electrochemical analysis of tumor biomarkers.
  • Wang P1, Wan Y2, Deng S1, Yang S3, Su Y4, Fan C5, Aldalbahi A6, Zuo X7.
  • Biosensors & bioelectronics.Biosens Bioelectron.2016 Dec 15;86:536-41. doi: 10.1016/j.bios.2016.07.025. Epub 2016 Jul 9.
  • Herein, an aptamer-initiated on-particle template-independent enzymatic polymerization (aptamer-OTEP) strategy for electrochemical aptasensor (E-aptasensor) is developed for analysis of cancer biomarker carcino-embryonic antigen (CEA). A pair of DNA aptamers is employed which can be specifically bon
  • PMID 27448543


  • 第79回東京女子医科大学学会総会シンポジウム「放射線治療の最近の進歩」(1)原発性悪性脳腫瘍
  • 前林 勝也
  • 東京女子医科大学雑誌 84(2), 60-66, 2014-04-25
  • 原発性脳腫瘍は悪性であっても中枢神経系外に転移することはまれである。また、悪性では境界が不明瞭で、十分な全摘をするのは困難である。さらに、脳内には血液脳関門が存在するため、化学療法薬剤の病変へ到達が十分ではなく、体幹部病変よりも効果が劣るのが一般的である。これらのことから、体幹部悪性腫瘍と比べ、原発性悪性脳腫瘍の治療には、局所治療である放射線治療の役割は大きく、どのようなタイミングで、どのような範 …
  • NAID 110009770441
  • 腫瘍マーカーからの診断 (特集 大腸癌の最新治療 : 治癒に向けた最先端研究) -- (臨床研究)
  • 風間 伸介,渡邉 聡明
  • 日本臨床 72(1), 71-76, 2014-01
  • NAID 40019920552


Key Points Tumor markers are substances found in the blood, urine, stool, other bodily fluids, or tissues of some patients with cancer. Tumor markers may be used to help diagnose cancer, predict a patient’s response to certain ...
Tumor Markers Definition Tumor markers are measurable biochemicals that are associated with a malignancy. They are either produced by tumor cells (tumor-derived) or by the body in response to tumor cells (tumor-associated).






  • n.

WordNet   license wordnet

「a writing implement for making a mark」

WordNet   license wordnet

「some conspicuous object used to distinguish or mark something; "the buoys were markers for the channel"」

WordNet   license wordnet

「a distinguishing symbol; "the owner''s mark was on all the sheep"」
marking, mark

PrepTutorEJDIC   license prepejdic

「印をつける人(道具) / (ゲームなどの)採点者 / 目印,目標」



  • n.

WordNet   license wordnet

「an abnormal new mass of tissue that serves no purpose」
tumour, neoplasm